{"id":215616,"date":"2026-02-20T08:03:00","date_gmt":"2026-02-20T13:03:00","guid":{"rendered":"https:\/\/news-you-need.com\/index.php\/2026\/02\/20\/cgt-catapult-establishes-technology-advisory-board-led-by-chair-phil-vanek\/"},"modified":"2026-02-20T08:05:41","modified_gmt":"2026-02-20T13:05:41","slug":"cgt-catapult-establishes-technology-advisory-board-led-by-chair-phil-vanek","status":"publish","type":"post","link":"https:\/\/news-you-need.com\/index.php\/2026\/02\/20\/cgt-catapult-establishes-technology-advisory-board-led-by-chair-phil-vanek\/","title":{"rendered":"CGT Catapult establishes Technology Advisory Board led by chair Phil Vanek"},"content":{"rendered":"<p><a href=\"https:\/\/pmlive.com\/pharma_news\/cgt-catapult-establishes-technology-advisory-board-led-by-chair-phil-vanek\/\">CGT Catapult establishes Technology Advisory Board led by chair Phil Vanek<\/a><\/p>\n<p><a href=\"https:\/\/pmlive.com\/pharma_news\/cgt-catapult-establishes-technology-advisory-board-led-by-chair-phil-vanek\/\">https:\/\/pmlive.com\/pharma_news\/cgt-catapult-establishes-technology-advisory-board-led-by-chair-phil-vanek\/<\/a><\/p>\n<p>Publish Date: <a href=\"publish_date]\">2026-02-20 08:03:00<\/a><\/p>\n<p>Source Domain: <a href=\"pmlive.com\">pmlive.com<\/a><\/p>\n<p><strong>Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy industry, has established a Technology Advisory Board to provide independent, strategic guidance. The board will support the CGT Catapult in identifying and removing barriers to the widespread adoption of advanced therapies.<\/strong><\/p>\n<p>The remit of the board will encompass areas including: data and digital; manufacturing and supply technology; product characterisation and testing; and novel patient treatment pathways. The board will identify opportunities and challenges arising from new technologies, as well as potential roadblocks to their widespread use.<\/p>\n<p>The board is made up of advanced therapy experts from across academia, industry and regulation:<\/p>\n<ul class=\"wp-block-list\">\n<li>Chair \u2013 Dr Phil Vanek, Founder, Redline Bioadvisors and Chief Commercialisation Officer, International Society for Cell &#038; Gene Therapy (ISCT)<\/li>\n<li>Dr Deborah Hursh, Consultant and former FDA Senior Investigator<\/li>\n<li>John Lunger, life science executive and strategic advisor<\/li>\n<li>Professor Masahiro Kino-oka, Professor in Department of Biotechnology, The University of Osaka<\/li>\n<li>Dr James McCafferty, Chief Information Officer, Wellcome Sanger Institute<\/li>\n<li>Ian Rees, Unit Manager Inspectorate Strategy and Innovation, Medicines and Healthcare Products Regulatory Agency (MHRA)<\/li>\n<li>Professor Susan Rosser, Director of the UK Centre for Mammalian Synthetic Biology and Co-director of the Edinburgh Genome Foundry, University of Edinburgh.<\/li>\n<\/ul>\n<p>In addition, from CGT Catapult, the board includes:<\/p>\n<ul class=\"wp-block-list\">\n<li>Dr Jim Faulkner, Chair of the Board<\/li>\n<li>Dr Nicole Mather, Non-Executive Director<\/li>\n<li>Dr Jacqueline Barry, Chief Clinical Officer<\/li>\n<li>Dr Stephen Ward, Chief Technology Officer.<\/li>\n<\/ul>\n<p>Dr Phil Vanek, Chair of the Technology Advisory Board, said: \u201cCGT Catapult has played a critical role in shaping the advanced therapy landscape for more than a decade, and I\u2019m&#8230;<\/p>\n<p><a href=\"https:\/\/pmlive.com\/pharma_news\/cgt-catapult-establishes-technology-advisory-board-led-by-chair-phil-vanek\/\">Source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>CGT Catapult establishes Technology Advisory Board led by chair Phil Vanek https:\/\/pmlive.com\/pharma_news\/cgt-catapult-establishes-technology-advisory-board-led-by-chair-phil-vanek\/ Publish Date: 2026-02-20&#8230;<\/p>\n","protected":false},"author":1,"featured_media":215617,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/pmlive.com\/wp-content\/uploads\/2026\/02\/Phil-Vanek.jpg","fifu_image_alt":"","footnotes":""},"categories":[8],"tags":[62],"class_list":["post-215616","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology","tag-innovation"],"_links":{"self":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/215616"}],"collection":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=215616"}],"version-history":[{"count":1,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/215616\/revisions"}],"predecessor-version":[{"id":215618,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/215616\/revisions\/215618"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/215617"}],"wp:attachment":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=215616"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=215616"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=215616"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}